Stock HAE HAEMONETICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Haemonetics Corporation

Equities

HAE

US4050241003

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-17 pm EDT 		5-day change 1st Jan Change
95.73 USD +0.98% Intraday chart for Haemonetics Corporation -0.14% +11.95%
May. 10 Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating MT
May. 09 Haemonetics Seeks Acquisitions CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Haemonetics: Fiscal Q4 Earnings Snapshot
AQ
Haemonetics : 4th Quarter FY24 Earnings Release
PU
Haemonetics : Q4 2024 Analysis Tables & Supplemental Information
PU
Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
PR
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
PR
Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge
AQ
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
PR
Haemonetics Corporation Completes Acquisition of Attune Medical
PR
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
PR
Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
PR
Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
PR
Haemonetics: Fiscal Q3 Earnings Snapshot
AQ
Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
PR
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024
PR
Haemonetics Corporation Completes Acquisition of OpSens Inc.
PR
Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference
PR
OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS
AQ
Haemonetics: Fiscal Q2 Earnings Snapshot
AQ
Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
PR
Haemonetics : to Acquire OpSens, Inc. Presentation
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HAE Stock
  4. News Haemonetics Corporation
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW